|
|
|
| home > white papers > The Promise and Challenge of Adaptive Design in Oncology Trials - Medpace |
|
|
 WHITE PAPERS |
|
Medpace
|
|
The Promise and Challenge of Adaptive Design in Oncology Trials
|
|
Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research.
Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Pharmaceutical Packaging and Labelling Summit in Zurich; ACG presentation
At next week’s Pharmaceutical Packaging and Labelling Summit in Zurich (18-19 June), Dr. Eugen Hertel from ACG will be speaking on: Challenges for Global Pharma companies to Implement Anti-Counterfeit Strategy for Russian Track & Trace Regulation. This presentation will include details around ‘the fight against counterfeit medicine - there have been and still are worldwide initiatives to make the supply chain and the safety of medicines secure. After large markets such as the USA and Europe passed their laws and regulations for the pharmaceutical manufacturing companies and established the IT infrastructure, Russia is now next on the move.
More info >> |
|
 |
White Papers |
 |
|
7 Common Myths about QP Training Debunked: A Guide for Senior Managers
RSSL
The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >> |
|
 |
Industry Events |
 |
BioPharm America™ 2019—12th Annual International Partnering Conference
11-12 September 2019, Boston Convention and Exhibition Center (BCEC), Boston, MA 02210 USA
BioPharm America™ is a unique partnering event that forms the nexus of discovery and
realization. Startup companies, established biotech and entrepreneurs from academia
attend in search of finance, pharma and development partners. The event format highlights
innovation and promotes new business relationships by bringing dealmakers from the life
science ecosystem together to engage and de-risk the enormous task of drug development.
Life science executives from around the world gather to identify, meet and to enter
into strategic relationships facilitated by partneringONE®, the world’s leading
web-based partnering system. BioPharm America is the only event in North America
based on the same reputable formula as EBD Group’s acclaimed European events
BIO-Europe® and BIO-Europe Spring®. BioPharm America annually attracts 800+ delegates
from over 500 companies who participated in 2,300+ scheduled one-to-one meetings.
BioPharm America is now part of Biotech Week Boston, and together they draw a total
of over 4,500 life science leaders, scientists and innovators.
More info >> |
|
|
|
